A closed-end investment fund managed by BlackRock that focuses on public and private companies across the healthcare and life sciences ecosystem, including biotechnology, pharmaceuticals, and medical technology. The fund seeks long-term capital appreciation and income through equity investments and ...
1 member of Congress has disclosed 1 trade in BlackRock Health Sciences Trust II (BMEZ), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-01-29 | John Hoeven | buy | $100K – $250K |